TRS85 Antibody

What cellular processes does TRS85 participate in and why is it important for autophagy research?

TRS85 (Transport protein particle complex III-specific subunit 85) is a specialized subunit that defines the TRAPPIII complex, one of three distinct TRAPP complexes in yeast. The core TRAPPI complex consists of six shared subunits (Bet3, Bet5, Trs20, Trs23, Trs31, and Trs33), while TRAPPIII specifically includes these core subunits plus Trs85 .

TRS85 participates in several key cellular processes:

• Autophagy regulation: Trs85 directly interacts with Atg9, a critical transmembrane protein involved in autophagosome formation. This interaction helps recruit the GTPase Ypt1 (Rab1 homolog) to the pre-autophagosomal structure (PAS), which is essential for autophagy initiation .

• Membrane trafficking: Trs85 serves as a membrane anchor for the TRAPPIII complex, which is crucial for both normal growth and autophagy .

• Vesicle tethering: As part of the TRAPPIII complex, Trs85 helps tether vesicles during membrane trafficking events .

• In plants: Trs85 plays a dual role in cellulose synthase complex trafficking by influencing both endocytosis and exocytosis processes .

Understanding TRS85's function is essential for autophagy research because it represents a critical link between membrane trafficking and autophagosome formation.

How can I validate the specificity of a TRS85 antibody in experimental systems?

Validating TRS85 antibody specificity requires multiple complementary approaches:

Genetic validation:

• Test antibody reactivity in wild-type versus trs85Δ cells or knockdown models

• Signal should be present in wild-type samples but absent or significantly reduced in knockout/knockdown samples

Biochemical validation:

• Perform immunoprecipitation (IP) using the TRS85 antibody and confirm identity by mass spectrometry

• Conduct competitive blocking experiments with recombinant TRS85 protein

• Verify detection of a protein with the expected molecular weight by Western blot

Functional validation in biological contexts:

• In co-immunoprecipitation experiments, TRS85 antibodies should pull down Trs85 but not other TRAPP subunits like Bet3, Trs31, or Trs33, unless complete TRAPPIII complex is being isolated

• Immunofluorescence patterns should match known localization of TRS85 (e.g., co-localization with autophagy markers under appropriate conditions)

Recent antibody validation techniques using CDR clustering approaches have shown promise for accurately predicting antibody specificities in complex scenarios .

What are the optimal conditions for TRS85 antibody use in co-immunoprecipitation studies?

Successful co-immunoprecipitation (co-IP) with TRS85 antibodies requires careful optimization:

Buffer composition:

• Use mild detergents (0.5% Triton X-100) that preserve protein-protein interactions

• Include protease inhibitor cocktails to prevent degradation

• Maintain physiological pH (typically 7.2-7.4)

• Use appropriate salt concentrations (typically 150mM NaCl)

Experimental considerations:

• For membrane-bound TRS85 interactions, gentle solubilization is critical as harsh detergents may disrupt associations

• Research has shown that when Atg9 vesicles bound to anti-FLAG beads were treated with 0.5% Triton X-100, Trs85 was not efficiently released, indicating strong interaction with Atg9

• In contrast, Ypt1 was completely released after the same treatment, demonstrating different binding properties

Recommended co-IP protocol for TRS85-Atg9 interaction studies:

• Harvest cells and prepare lysates in buffer containing 0.5% Triton X-100

• Incubate with TRS85 antibody (or anti-tag antibody for tagged constructs)

• Capture complexes with Protein A/G beads

• Wash with buffer containing 0.5% Triton X-100

• Elute bound proteins and analyze by immunoblotting

This approach has successfully demonstrated that Trs85 interacts with Atg9 independently of other TRAPPIII subunits .

How do I interpret TRS85 antibody staining patterns in relation to autophagy structures?

Interpreting TRS85 antibody staining requires understanding its dynamic localization during autophagy:

Expected staining patterns:

• Under normal conditions: TRS85 appears as punctate structures in the cytoplasm

• During autophagy induction: TRS85 increasingly colocalizes with autophagy markers at the PAS

• In yeast, GFP-tagged Ypt1 (which is recruited by Trs85) shows punctate structures, with one dot frequently colocalizing with the PAS marker RFP-Ape1 (25% colocalization under rapamycin treatment)

Comparative localization data:

This data demonstrates that both Trs85 and Atg9 are required for proper Ypt1 recruitment to the PAS during autophagy .

Validation controls:

• Always compare staining in autophagy-induced versus basal conditions

• Include trs85Δ cells as negative controls

• Co-stain with established autophagy markers (Atg8/LC3, Atg9)

• Consider super-resolution microscopy for detailed colocalization analysis

What sample preparation methods optimize TRS85 antibody performance for immunofluorescence?

Optimal sample preparation for TRS85 immunofluorescence depends on the experimental system:

For yeast cells:

• Fix cells with 4% paraformaldehyde for 15-30 minutes

• Digest cell wall with zymolyase or lyticase in sorbitol buffer

• Permeabilize with 0.1% Triton X-100

• Block with 1-3% BSA or 5% normal serum

• Incubate with TRS85 antibody at optimized dilution (typically 1:100-1:500)

• Use fluorophore-conjugated secondary antibodies compatible with imaging system

For mammalian cells:

• Fix cells with 4% paraformaldehyde (10 minutes) or cold methanol (5 minutes)

• Permeabilize with 0.1-0.2% Triton X-100 if using paraformaldehyde fixation

• Block with 5% normal serum or 3% BSA

• Incubate with TRS85 antibody overnight at 4°C

• Wash extensively to minimize background

• Image within 24-48 hours of staining for optimal signal

Critical considerations:

• Membrane proteins like TRS85 can be sensitive to fixation methods

• Cross-validation with GFP-tagged TRS85 localization is recommended

• For autophagy studies, compare staining patterns in fed versus starved/rapamycin-treated conditions

How can I use TRS85 antibodies to dissect the mechanism of Atg9 vesicle tethering?

TRS85 antibodies can be powerful tools to investigate the Atg9 vesicle tethering mechanism:

Experimental approach for studying TRS85-mediated vesicle tethering:

• Isolation of Atg9 vesicles with associated tethering proteins

  • Immunoprecipitate Atg9 with epitope-tagged constructs (e.g., Atg9-6xFLAG)

  • Detect co-precipitated TRS85 and other tethering factors (Ypt1) by immunoblotting

  • Research has shown that both Trs85 and Ypt1 co-precipitate with Atg9-6xFLAG regardless of autophagy induction status

• Assessment of tethering factor dependencies

  • Compare TRS85 and Ypt1 co-precipitation with Atg9 in various mutant backgrounds

  • Studies reveal that Ypt1 association with Atg9 vesicles is reduced in trs85Δ cells, confirming that Ypt1 recruitment requires TRS85

  • The co-precipitation assay can be performed in atg11Δ atg17Δ cells where PAS formation is blocked to determine if interactions occur independent of autophagosome formation

• Microscopy-based tethering analysis

  • Use TRS85 antibodies for immunofluorescence to visualize colocalization of tethering factors

  • Perform live imaging with fluorescently tagged proteins to monitor dynamics

  • Analyze vesicle clustering in vitro using purified components

This research approach has established that TRS85 serves as a direct link between Atg9 vesicles and the TRAPPIII-mediated recruitment of Ypt1, which is essential for vesicle tethering during autophagosome formation .

What methodologies can determine if TRS85 interacts directly with Atg9?

Multiple complementary methodologies can conclusively demonstrate direct TRS85-Atg9 interaction:

Detergent sensitivity analysis:

• Immunoprecipitate Atg9 (e.g., using Atg9-6xFLAG)

• Treat precipitated complexes with 0.5% Triton X-100 on ice

• Analyze proteins released versus retained on beads

• Research shows Trs85 remains bound to Atg9 after detergent treatment while Ypt1 is released, suggesting direct Trs85-Atg9 interaction

In vitro binding assays:

• Prepare Trs85-bound beads using TAP-tagged Trs85 and IgG-conjugated beads

• Isolate Atg9 vesicles from yeast cells

• Incubate Atg9 vesicles with Trs85-bound beads

• Assess binding efficiency compared to control (e.g., Trs65-bound beads)

• Studies have demonstrated that Atg9 vesicles associate efficiently with Trs85-bound beads but not with Trs65-bound beads, confirming specificity

Yeast two-hybrid analysis:

• Clone different domains of Trs85 and Atg9 into two-hybrid vectors

• Test pairwise interactions by monitoring reporter gene activity

• Research has shown that the N-terminal half of Trs85 interacts with the N-terminal cytoplasmic domain of Atg9

Domain mapping experiments:
Generate truncation mutants to define precise interaction regions between TRS85 and Atg9.

These methodologies collectively provide strong evidence for direct interaction between TRS85 and Atg9 .

How can I determine if TRS85 antibody-detected structures represent the complete TRAPPIII complex versus free TRS85?

Distinguishing between complete TRAPPIII complex and free TRS85 requires specialized approaches:

Differential immunoprecipitation strategy:

• Perform parallel immunoprecipitations using antibodies against:

  • TRS85 (specific to TRAPPIII)

  • Core TRAPP subunits (present in all TRAPP complexes)

  • TRAPPII-specific subunits (for comparison)

• Analyze precipitated material by immunoblotting for all TRAPP components

• Research has shown that when Atg9-6xFLAG is immunoprecipitated, only Trs85 is co-precipitated while other TRAPP subunits (Bet3, Trs31, Trs33, Trs65) are not detected

Size-based separation techniques:

• Use sucrose gradient fractionation or size-exclusion chromatography

• Analyze fractions by immunoblotting with TRS85 antibodies

• Compare with fractionation patterns of core TRAPP subunits

• Free TRS85 will appear in lower molecular weight fractions compared to the complete TRAPPIII complex

Visualization of complex integrity:

• Perform structured illumination microscopy (SIM) with dual labeling:

  • TRS85 antibody

  • Antibody against core TRAPP component (e.g., Bet3)

• Analyze colocalization patterns:

  • Complete overlap indicates intact TRAPPIII complex

  • TRS85-only structures suggest free TRS85

Understanding TRAPP complex composition is critical as different TRAPP complexes have distinct functions:

Research indicates that Trs85's interaction with Atg9 occurs independently of other TRAPP subunits, suggesting functional roles beyond the complete TRAPPIII complex .

What techniques can quantify TRS85 membrane association using antibody-based methods?

Quantitative assessment of TRS85 membrane association can be achieved through several antibody-based approaches:

Subcellular fractionation with immunoblotting:

• Prepare cytosolic and membrane fractions using differential centrifugation

• Analyze fractions by immunoblotting with TRS85 antibodies

• Quantify band intensities to calculate membrane-to-cytosol ratio

• Compare ratios under different conditions (e.g., starvation, rapamycin treatment)

Liposome binding assays:

• Prepare synthetic liposomes of defined composition

• Incubate with purified TRAPPIII complex (with or without Trs85)

• Sediment liposomes by centrifugation

• Analyze bound proteins by immunoblotting with TRS85 antibodies

• Research has demonstrated that the intact TRAPPIII complex binds to synthetic liposomes in a Trs85-dependent manner

Protease protection assays:

• Isolate membrane fractions containing TRS85

• Treat with proteases with or without membrane permeabilization

• Analyze protected fragments using TRS85 antibodies

• Determine membrane association topology

Immunofluorescence-based quantification:

• Perform immunofluorescence with TRS85 antibodies

• Co-stain with membrane markers

• Capture high-resolution images using confocal or super-resolution microscopy

• Quantify colocalization using Pearson's or Manders' coefficients

• Analyze intensity profiles across cellular regions

These techniques have collectively established that Trs85 serves as a critical membrane anchor for the TRAPPIII complex, which is essential for its function in both normal growth and autophagy .

How can I use TRS85 antibodies to investigate cell-type specific functions of TRAPPIII in multi-tissue organisms?

Investigating cell-type specific functions of TRAPPIII requires specialized applications of TRS85 antibodies:

Tissue microarray analysis:

• Prepare tissue microarrays with multiple tissue types

• Perform immunohistochemistry with TRS85 antibodies

• Quantify staining patterns across different cell types

• Correlate with autophagy markers in serial sections

Fluorescence-activated cell sorting (FACS) with intracellular staining:

• Prepare single-cell suspensions from tissues

• Fix and permeabilize cells

• Stain with TRS85 antibodies and cell-type specific markers

• Sort cells based on marker expression

• Analyze TRS85 levels in different cell populations

Proximity ligation assay (PLA) for tissue sections:

• Prepare tissue sections

• Perform PLA using TRS85 antibody and antibodies against interaction partners

• Quantify interaction signals in different cell types

• Compare interaction patterns across tissues

Cell-type specific analysis in plant systems:

• For plant tissues, prepare sections from different organs

• Perform immunofluorescence with TRS85 antibodies

• Co-stain with cellulose synthase markers

• Research in Arabidopsis has shown that Trs85 interacts with cellulose synthase-interactive protein 1 (CSI1) and affects cellulose content and synthesis

Comparative expression analysis:

Understanding cell-type specific functions of TRS85 provides insights into how the TRAPPIII complex is adapted for specialized roles across different tissues and organisms .

How can I address non-specific binding issues when using TRS85 antibodies?

Non-specific binding with TRS85 antibodies can be addressed through systematic optimization:

Common causes and solutions:

• Antibody concentration too high

  • Perform titration experiments to determine optimal concentration

  • For Western blots, typically test 1:500-1:5000 dilutions

  • For immunofluorescence, try 1:50-1:500 dilutions

• Insufficient blocking

  • Extend blocking time (1-2 hours at room temperature or overnight at 4°C)

  • Try different blocking agents (BSA, milk, normal serum)

  • For membrane proteins like TRS85, 5% BSA often works better than milk

• Cross-reactivity with related proteins

  • Validate using knockout/knockdown controls

  • Pre-absorb antibody with recombinant protein from related family members

  • Consider using monoclonal antibodies for higher specificity

• Sample preparation issues

  • Ensure complete solubilization of membrane proteins

  • Include appropriate detergents (0.5% Triton X-100 has been successful for TRS85 studies)

  • Optimize fixation conditions for immunofluorescence

Research on antibody specificity indicates that validation through multiple complementary approaches, including genetic knockouts and recombinant protein controls, is essential for confirming binding specificity .

What controls are essential when studying TRS85-dependent protein interactions with co-immunoprecipitation?

Essential controls for TRS85 co-immunoprecipitation studies include:

Negative controls:

• Genetic knockout/knockdown

  • Use trs85Δ cells as negative controls

  • Compare with wild-type cells to identify specific interactions

• Isotype control antibodies

  • Use non-specific antibodies of the same isotype

  • Identifies non-specific binding to antibody constant regions

• Beads-only control

  • Process sample with beads but no antibody

  • Identifies proteins binding non-specifically to beads

Specificity controls:

• Competitive blocking

  • Pre-incubate antibody with recombinant TRS85

  • Should eliminate specific signal

• Detergent sensitivity tests

  • Treat immunoprecipitated complexes with different detergents

  • Research shows Trs85 remains bound to Atg9 after 0.5% Triton X-100 treatment while Ypt1 is released

• Reciprocal co-immunoprecipitation

  • Immunoprecipitate with antibodies against interaction partners

  • Then probe for TRS85 presence

Condition controls:

• Compare autophagy-induced versus basal conditions

  • Research shows Trs85 and Ypt1 co-precipitate with Atg9-6xFLAG in both growing and rapamycin-treated cells

• Test in various mutant backgrounds

  • Perform co-IP in atg11Δ atg17Δ cells where PAS formation is blocked

  • Studies demonstrate Trs85-Atg9 interaction occurs even in these cells, indicating it's independent of PAS formation

These controls collectively ensure that observed interactions are specific and biologically relevant.

How can I optimize TRS85 antibody-based detection in systems with low expression levels?

Detecting low-abundance TRS85 requires specialized approaches:

Signal amplification methods:

• Tyramide signal amplification (TSA)

  • Use HRP-conjugated secondary antibodies with tyramide substrates

  • Provides 10-50x signal enhancement

  • Particularly useful for immunohistochemistry/immunofluorescence

• Biotin-streptavidin systems

  • Use biotinylated secondary antibodies followed by streptavidin-conjugated reporters

  • Multiple biotin-binding sites on streptavidin amplify signal

Sample enrichment strategies:

• Immunoprecipitation before detection

  • Concentrate TRS85 from large sample volumes

  • Elute under conditions compatible with downstream applications

• Subcellular fractionation

  • Isolate membrane fractions where TRS85 is enriched

  • Reduces background from cytosolic proteins

Enhanced detection techniques:

• Highly-sensitive chemiluminescent substrates

  • Use femtogram-sensitive ECL substrates for Western blotting

  • Extend exposure times with low-noise detection systems

• High-sensitivity microscopy

  • Use photomultiplier tube (PMT) detectors or electron-multiplying CCD cameras

  • Apply deconvolution algorithms to improve signal-to-noise ratio

What experimental designs can distinguish between direct and indirect TRS85 protein interactions?

Distinguishing direct from indirect TRS85 interactions requires specialized experimental approaches:

In vitro binding assays with purified proteins:

• Pull-down with recombinant proteins

  • Express and purify TRS85 and potential interaction partners

  • Perform binding assays without cellular components

  • Research has shown that Atg9 vesicles bind directly to Trs85-bound beads but not Trs65-bound beads

• Surface plasmon resonance (SPR)

  • Immobilize purified TRS85 on sensor chip

  • Measure direct binding kinetics with potential partners

  • Quantify association and dissociation constants

Yeast two-hybrid analysis:

• Direct interaction testing

  • Clone TRS85 and potential partners into Y2H vectors

  • Test activation of reporter genes

  • Studies have shown that the N-terminal half of Trs85 interacts with N-terminal cytoplasmic domain of Atg9 in Y2H assays

Crosslinking mass spectrometry:

• Zero-length crosslinking

  • Use EDC or other zero-length crosslinkers that only connect directly contacting proteins

  • Analyze crosslinked peptides by mass spectrometry

  • Identifies direct protein-protein contacts

Systematic domain mapping:

• Truncation and mutation analysis

  • Generate series of TRS85 truncations/mutations

  • Test interaction with full-length partner proteins

  • Identify specific domains required for direct binding

Research using these approaches has established that Trs85 directly interacts with Atg9 through its N-terminal domain, while its interaction with Ypt1 is likely indirect .

How can I verify TRS85 antibody results across different model organisms?

Verifying TRS85 antibody results across model organisms requires careful cross-validation:

Sequence homology analysis:

• Epitope conservation assessment

  • Align TRS85 sequences from different species

  • Determine if antibody epitope is conserved

  • Generate species-specific antibodies if needed

Cross-species validation approaches:

• Heterologous expression systems

  • Express TRS85 from different species in a common host

  • Test antibody reactivity against each ortholog

  • Determine cross-reactivity profile

• Complementary genetic approaches

  • Validate antibody staining in knockout/knockdown models

  • Perform rescue experiments with orthologs from different species

Comparative functional studies:

• Assess conserved interactions

  • Test if TRS85-Atg9 interaction is conserved across species

  • Compare subcellular localization patterns

  • Research in yeast has established Trs85-Atg9 interaction , while in plants Trs85 interacts with cellulose synthase-interactive protein 1

Cross-species comparison table:

Understanding both conserved and divergent aspects of TRS85 function across species can provide valuable insights into its fundamental roles and evolutionary adaptations .